Complement and complement regulatory protein in allogeneic and xenogeneic kidney transplantation.

Area of Science:

• Immunology
• Nephrology
• Transplantation Science

Background:

• Kidney transplantation is the optimal treatment for end-stage renal disease, surpassing dialysis.
• Immune rejection poses a significant threat to kidney transplant success.
• The complement system is a critical factor in various rejection types, including T-cell- and antibody-mediated rejection.

Purpose of the Study:

• To review the role of the complement system in kidney transplantation.
• To explore advancements in complement regulatory strategies.
• To discuss therapeutic approaches for improving transplant outcomes.

Main Methods:

• Review of current literature on complement system activation and regulation in kidney transplantation.
• Analysis of recent developments in genetic engineering for xenotransplantation.
• Examination of potential therapeutic interventions targeting the complement system.

Main Results:

• Complement activation contributes to graft damage and failure in allogeneic transplantation.
• Transgenic pigs expressing human complement regulatory proteins show promise for reducing xenotransplantation rejection.
• Understanding complement mechanisms is crucial but not fully elucidated.

Conclusions:

• Effective management of the complement system is essential for successful kidney transplantation.
• Targeting complement pathways offers potential therapeutic strategies to enhance graft survival.
• Further research is needed to fully understand and control complement activation in transplantation.